Lisa Bright
Director/Board Member at ASCENDIS PHARMA A/S
Net worth: 59 107 $ as of 2024-03-30
Profile
Lisa Jane Bright is currently the Chairman at Resolution Therapeutics Ltd.
She also holds the position of Non-Executive Director at Dechra Pharmaceuticals Plc, Independent Director at Ascendis Pharma A, Director at Immedica Pharma AB, Advisor at DRI Capital, Inc., Executive Partner at Syncona Partners LLP, and President-International at Intercept Pharma Europe Ltd.
Her former positions include Vice President at Gilead Sciences, Inc., President-International at Intercept Pharmaceuticals, Inc., VP-Commercial Planning & Operations at GSK Plc, General Manager at Gilead Sciences Ireland UC, and General Manager at Gilead Sciences Ltd.
Ms. Bright completed her undergraduate degree at University College London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ASCENDIS PHARMA A/S
0.00% | 2023-12-30 | 391 ( 0.00% ) | 59 107 $ | 2024-03-30 |
Lisa Bright active positions
| Companies | Position | Start |
|---|---|---|
| ASCENDIS PHARMA A/S | Director/Board Member | 2017-03-31 |
| DECHRA PHARMACEUTICALS | Director/Board Member | 2019-01-31 |
Intercept Pharma Europe Ltd.
 Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The private company is based in Bristol, UK. | Corporate Officer/Principal | 2016-06-30 |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Consultant / Advisor | - |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Consultant / Advisor | - |
Immedica Pharma AB
 Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Director/Board Member | - |
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Chairman | - |
Former positions of Lisa Bright
| Companies | Position | End |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2020-12-31 |
| Gilead Sciences Ireland UC | Corporate Officer/Principal | 2014-10-31 |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Lisa Bright
| University College London | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| DECHRA PHARMACEUTICALS | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| Private companies | 7 |
|---|---|
DRI Capital, Inc.
DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Finance |
Immedica Pharma AB
Immedica Pharma AB Medical DistributorsDistribution Services Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Distribution Services |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Finance |
| Gilead Sciences Ireland UC | |
Gilead Sciences Ltd.
 Gilead Sciences Ltd. Medical DistributorsDistribution Services Founded in 1990, Gilead Sciences Ltd. is a pharmaceutical wholesaler that is part of Gilead Sciences, Inc. The private company is based in London, UK and specializes in the distribution of pharmaceutical products. | Distribution Services |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The private company is based in Bristol, UK. | Commercial Services |
Resolution Therapeutics Ltd.
Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Lisa Bright
